Centiva Capital’s Core Laboratories CLB Stock Holding History

Centiva Capital’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,316	Closed	-$173K	–	1879
2026 Q1	$173K	Buy	+10,316	New	+$185K	﹤0.01%	1308

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Centiva Capital's CLB Position: Q2 2026 in Review

Centiva Capital sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 10,316 shares — an estimated $173K sold.

Centiva Capital first reported a position in CLB in Q1 2026 and held it in 1 quarter. The position peaked at $173K in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Centiva Capital reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
Centiva Capital sold 10,316 Core Laboratories shares in Q2 2026, an estimated $173K.
Centiva Capital first reported a position in Core Laboratories in Q1 2026 and held it in 1 quarter.
Centiva Capital's Core Laboratories position peaked at $173K in Q1 2026.
186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.